Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Neurologic indications for therapeutic plasma exchange: 2011 update.
Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment.
Optic neuritis and TNF antagonists in IBD.
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia.
The complement and immunoglobulin levels in NMO patients.
The best basic science paper on multiple sclerosis in 2012: Commentary.
Increased structural white and grey matter network connectivity compensates for functional decline in early multiple sclerosis.
Distinct origins, gene expression and function of microglia and monocyte-derived macrophages in CNS myelin injury and regeneration.
Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.
Altered Serum Cytokine Profiles in Relapse Phase of Relapsing-Remitting Multiple Sclerosis.
In vivo amyloid aggregation kinetics tracked by time-lapse confocal microscopy in real-time.
HIV and decreased risk of multiple sclerosis: role of low CD4+ lymphocyte count and male prevalence.
[Cannabis: Effects in the Central Nervous System. Therapeutic, societal and legal consequences].
The regulator's perspective: How should new therapies and follow-on products for MS be clinically evaluated in the future?
Combination treatment of fingolimod with antidepressants in relapsing-remitting multiple sclerosis patients with depression: a multicentre, open-label study - REGAIN.
Clinical Heterogeneity of Guillain-Barré Syndrome in the Emergency Department: Impact on Clinical Outcome.
Genetics of rat neuroinflammation.
Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
Retraction: A. Amedei et al. Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies. Int. J. Mol. Sci. 2012, 13, 13438-13460.
Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
Is distal motor and/or sensory demyelination a distinctive feature of anti-MAG neuropathy?
Rapid measurement of brain macromolecular proton fraction with transient saturation transfer MRI.
Cost of Illness of Multiple Sclerosis - A Systematic Review.
Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells.
Dataset of mRNA levels for dopaminergic receptors, adrenoceptors and tyrosine hydroxylase in lymphocytes from subjects with clinically isolated syndromes.
Pages
« first
‹ previous
…
701
702
703
704
705
706
707
708
709
…
next ›
last »